Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Centelles – page 124

3 673 clinical trials in Centelles, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Centelles at a glance
3 673
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

3 673 trials in Centelles

Open in trial search

Autoimmune myositis

Not yet recruiting

A study to evaluate the safety and effectiveness of CABA-201, fludarabine, and cyclophosphamide in patients with active inflammatory myopathy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:CABA-201
  • Sponsor:Cabaletta Bio Inc.

Embolism

Not yet recruiting

A study to evaluate the effectiveness of REGN7508 for preventing blood clots in adults with solid tumors undergoing cancer treatment.

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg4 S228P Monoclonal Antibody Against Factor Xi And Activated Factor Xi
  • Sponsor:Regeneron Pharmaceuticals Inc.

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Zampilimab
  • Sponsor:Chiesi Farmaceutici S.p.A.

A study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Vall D Hebron Institute Of Oncology

Type 2 diabetes mellitus

Not yet recruiting

A study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · Healthy volunteers
  • Substances:NNC0662-0419
  • Sponsor:Novo Nordisk A/S

Hereditary haemochromatosis

Not yet recruiting

A study to evaluate the effectiveness and safety of vamifeport in adults with hereditary hemochromatosis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Vamifeport trihydrochloride
  • Sponsor:CSL Behring LLC

Multiple sclerosis

Not yet recruiting

Study of the safety and effectiveness of tolDC therapy in patients with progressive forms of multiple sclerosis

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Toldc
  • Sponsor:Antwerp University Hospital

Graft versus host disease

Not yet recruiting

Safety and Efficacy of MaaT013 with Vancomycin in Children and Adolescents with Gastrointestinal Acute Graft‑versus‑Host Disease

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Vancomycin
  • Sponsor:Maat Pharma

Neoplasm

Not yet recruiting

A study to evaluate the safety and effectiveness of BMS-986523 alone or in combination with a drug combination for patients with advanced solid tumors and KRAS alterations.

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:BMS-986523
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Hepatocellular carcinoma

Not yet recruiting

A study to evaluate the safety and effectiveness of PF-08634404 and ipilimumab in adults with advanced or spreading liver cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Pfizer Inc.

Non-small cell lung cancer

Not yet recruiting

A study to evaluate the safety and effectiveness of petosemtamab and pembrolizumab in adults with non-small cell lung cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Merus B.V.

Device related infection

Not yet recruiting

Using fludeoxyglucose (18F) in PET/CT imaging to diagnose and monitor cardiovascular device infections

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Centelles

What the registry says about research in the country

01 Infectious Disease Prevention

Comprehensive research focusing on viral infections including studies evaluating vaccines against SARS-CoV-2, Herpes Zoster, and Cytomegalovirus. Multiple trials are examining vaccine efficacy and immune response in different age groups.

  • COVID-19 Vaccine Development
  • Viral Disease Prevention
  • Vaccine Safety Studies

Special attention is given to vaccine co-administration studies and booster dose evaluations in various populations.

02 Respiratory Health

Innovative clinical research examining treatments for respiratory conditions, including studies on RSV vaccines for older adults and asthma medication delivery systems. These trials aim to enhance treatment options for respiratory diseases.

  • RSV Prevention
  • Asthma Management
  • Pneumococcal Disease

Focus on developing effective preventive measures and treatments for respiratory infections.

03 Cardiovascular Health

Advanced research into cardiovascular disease prevention and treatment, with emphasis on managing hypercholesterolemia and reducing major adverse cardiovascular events. Studies evaluate new therapeutic approaches for heart health.

  • Cholesterol Management
  • Cardiovascular Risk Reduction
  • Preventive Cardiology

Trials focus on innovative medications and preventive strategies for cardiovascular health improvement.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.